Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaccine

Foot-and-mouth disease would devastate Australia’s graziers if it got in. Here’s how a new vaccine might help

It sounds innocuous. But foot-and-mouth disease is one of the world’s most economically devastating diseases affecting livestock.

The Conversation

World-first gonorrhoea vaccine rolled out across UK amid record levels of infection

Antibiotic-resistant strains of the infection are on the rise

The Independent UK

Gonorrhoea vaccine becomes available at sexual health clinics in England

The programme is targeted to those most at risk and could prevent up to 100,000 cases.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

AMA and other medical associations are kicked out of CDC vaccine workgroups

U.S. health officials have told more than a half-dozen of the nation’s top medical organizations that they will no longer help establish vaccination recommendations

The Independent UK

Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector

Shares of Novavax Inc (NASDAQ:NVAX) are trading lower Friday morning, appearing to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna Inc (NASDAQ:MRNA) reported disappointing second-quarter financial results and cut its full-year forecast.

Benzinga

Shingles vaccination rates rose during the COVID-19 pandemic, but major gaps remain for underserved groups

Vaccination against shingles increased among adults age 50 and older in the U.S. during the COVID-19 pandemic, but not equally across all population groups. That’s the key finding from a new study my colleagues and I published in the journal Vaccine.

The Conversation

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

1 Blue-Chip Dividend Stock That Still Has Room to Run

This pharmaceutical leaders offers a combination of growth, income, and innovation.

Barchart

This rare flu complication is on the rise in otherwise healthy children

This year was one of the deadliest flu seasons for children in more than 20 years

The Independent UK

Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales

Sanofi SA (NASDAQ:SNY) reported second-quarter sales of $11.33 billion (€9.99 billion euros), narrowly missing the consensus of $11.53 billion.

Benzinga

RFK Jr.’s ‘information crisis’ has doctors ditching the CDC to save your kids

Real doctors want to help you, unsurprisingly.

We Got This Covered

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna Inc. (NASDAQ:MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Benzinga

Parents urged to prioritise vaccine catch-ups as measles cases remain high

The latest measles data from the UK Health Security Agency shows there have been 145 cases since the last report on July 3.

Evening Standard

Inside the race to cure cancer: ‘We’re at the cusp of a golden era of treatment’

From new vaccines to predictive AI, Kate Wills investigates whether cancer is about to be beaten

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Vaccine researcher with green card held at San Francisco airport for a week and faces deportation

Family of Tae Heung ‘Will’ Kim, believes detention may be result of South Korean man’s decade-old marijuana misdemeanor

LiveScience

Experimental HIV vaccines show promise in early safety test

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

The Independent UK

Ousted vaccine panel members say rigorous science is being abandoned

Seventeen experts ousted from a U.S. vaccine committee are expressing little faith in what the panel has become

International Business Times UK

Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job

Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns

Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks.

LiveScience

'Universal' cancer vaccine heading to human trials could be useful for 'all forms of cancer'

A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study finds. It's now in early human trials.

The Guardian - US

FDA’s top vaccine official leaves post after less than four months

Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions

Benzinga

GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 guidance.

The Guardian - US

US medical groups fill gap with own vaccine guides amid ‘information crisis’

As official health guidance changes, scientific groups are stepping in with evidence-based recommendations

Barchart

1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year

This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so again.

Benzinga

Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'

Health and Human Services Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program, describing the system as fundamentally broken and failing its intended purpose.

1 … 24 25 26 27

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UK Health Security Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.